The Prognostic Significance of Serum Lactate Dehydrogenase Levels in Syrian AML Patients
Abstract
Acute myeloid leukemia (AML) is a heterogeneous group of myelogenous disorders that result from the proliferation of immature monoclonal myeloblastic cells within the bone marrow and their spread to the peripheral blood and to other organs. The development in genetic techniques has greatly contributed to our understanding of the mechanism of acute myeloid leukemia and its warning, especially in normal karyotype patients, and opened new horizons for the search for targeted treatments for these gene disorders responsible for the occurrence of the disease and perhaps its full treatment in the future, but so far these methods are still expensive in our society, which prompted us to search for prognostic factors that are easy to perform and inexpensive like determining the serum level of lactate dehydrogenase enzyme (LDH), so we studied in this research the association between serum LDH levels and the prognostic significance in AML patients, the study was conducted on 100 patients who reviewed the Division of Hematology and Oncology, in Tishreen University Hospital, a significant association was found between high levels of LDH, low survival and poor prognosis in these patients, and there was a relation between the presence of the FMS Like Tyrosine Kinase (FLT3) mutation and high levels of LDH, which indicates a link between the presence of this mutation and the bad prognosis. The accompanying disadvantages, we conclude from this study the importance of conducting LDH as a routine analysis of prognostic value in patients with AML.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.